NORTHERN TRUST CORP - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 114 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.9%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$600,854
+51.8%
324,786
-8.9%
0.00%
Q4 2022$395,868
-49.2%
356,638
+7.0%
0.00%
Q3 2022$779,000
-33.9%
333,156
-14.4%
0.00%
Q2 2022$1,179,000
-47.8%
389,280
+17.0%
0.00%
Q1 2022$2,258,000
-22.0%
332,588
-4.1%
0.00%
Q4 2021$2,894,000
+11.1%
346,722
-1.1%
0.00%
Q3 2021$2,605,000
-10.5%
350,647
-18.1%
0.00%
-100.0%
Q2 2021$2,909,000
+12.1%
427,885
+69.4%
0.00%
Q1 2021$2,594,000
+18.1%
252,600
-19.5%
0.00%
Q4 2020$2,196,000
-13.1%
313,640
+1.3%
0.00%
-100.0%
Q3 2020$2,526,000
+13.3%
309,571
-4.2%
0.00%0.0%
Q2 2020$2,230,000
+139.3%
323,172
+64.6%
0.00%
Q1 2020$932,000
-38.2%
196,279
+13.7%
0.00%
Q4 2019$1,507,000
+150.3%
172,593
-4.5%
0.00%
Q3 2019$602,000
-35.8%
180,757
-4.5%
0.00%
Q2 2019$937,000
-17.7%
189,363
+3.0%
0.00%
Q1 2019$1,139,000
+84.0%
183,759
-0.0%
0.00%
Q4 2018$619,000
-48.7%
183,824
-1.0%
0.00%
Q3 2018$1,206,000
-2.4%
185,679
+15.1%
0.00%
Q2 2018$1,236,000
-62.0%
161,357
+10.8%
0.00%
-100.0%
Q1 2018$3,256,000
+70.0%
145,673
-3.0%
0.00%
Q4 2017$1,915,000
-15.0%
150,185
+3.9%
0.00%
-100.0%
Q3 2017$2,252,000
+77.5%
144,579
+59.9%
0.00%
Q2 2017$1,269,000
+73.4%
90,412
+171.6%
0.00%
Q1 2017$732,00033,2920.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TRV GP II, LLC 10,230,349$63,428,00041.36%
TRV GP III, LLC 3,048,780$18,902,0009.26%
Omega Fund Management, LLC 1,059,930$6,572,0001.39%
Alambic Investment Management, L.P. 50,622$314,0000.13%
Spark Investment Management LLC 244,300$1,514,0000.07%
ALGERT GLOBAL LLC 14,182$88,0000.05%
Redmile Group, LLC 254,590$1,578,0000.05%
Granahan Investment Management 125,533$778,0000.04%
GSA CAPITAL PARTNERS LLP 38,602$239,0000.02%
Frontier Wealth Management LLC 27,099$168,0000.02%
View complete list of JOUNCE THERAPEUTICS INC shareholders